Description

Pleximmune^TM is a blood test, which can determine whether your patient is at increased or decreased risk of rejection. This information, combined with available clinical information may help you plan treatment for your patient.

The Pleximmune^TM test:

• Has been tested in over 200 recipients of liver or intestine transplants.
• Measures rejection-risk based on the anti-donor activity of recipient lymphocytes, which are known to cause transplant rejection.
• Categorizes the individual recipient simply as one at increased or decreased risk of transplant rejection.
• Has high sensitivity and specificity for predicting transplant rejection.